カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ポリオウイルスワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Poliovirus Vaccine Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8571 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：71 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Poliovirus Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるのポリオウイルスワクチン市場規模と予測を収録しています。・世界のポリオウイルスワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のポリオウイルスワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のポリオウイルスワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「不活化ポリオワクチン（IPV）」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ポリオウイルスワクチンのグローバル主要企業は、Sanofi、 GSK、 Bibcol、 Serum Institute、 Tiantan Biological、 IMBCA、 Panacea Biotec Ltd、 Bio-Med、 Halfkin Bio-Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ポリオウイルスワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のポリオウイルスワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のポリオウイルスワクチン市場：タイプ別市場シェア、2022年
・不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）

世界のポリオウイルスワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のポリオウイルスワクチン市場：用途別市場シェア、2022年
・公共、民間

世界のポリオウイルスワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のポリオウイルスワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるポリオウイルスワクチンのグローバル売上、2018年-2023年
・主要企業におけるポリオウイルスワクチンのグローバル売上シェア、2022年
・主要企業におけるポリオウイルスワクチンのグローバル販売量、2018年-2023年
・主要企業におけるポリオウイルスワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi、 GSK、 Bibcol、 Serum Institute、 Tiantan Biological、 IMBCA、 Panacea Biotec Ltd、 Bio-Med、 Halfkin Bio-Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
ポリオウイルスワクチン市場の定義
市場セグメント
世界のポリオウイルスワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のポリオウイルスワクチン市場規模
世界のポリオウイルスワクチン市場規模：2022年 VS 2029年
世界のポリオウイルスワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのポリオウイルスワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のポリオウイルスワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）
ポリオウイルスワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：公共、民間
ポリオウイルスワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別ポリオウイルスワクチン市場規模 2022年と2029年
地域別ポリオウイルスワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 GSK、 Bibcol、 Serum Institute、 Tiantan Biological、 IMBCA、 Panacea Biotec Ltd、 Bio-Med、 Halfkin Bio-Pharmaceuticals
...

Polio vaccines are vaccines used to prevent poliomyelitis (polio).
This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine. This report contains market size and forecasts of Poliovirus Vaccine in global, including the following market information:
Global Poliovirus Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Poliovirus Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Poliovirus Vaccine companies in 2022 (%)
The global Poliovirus Vaccine market was valued at US$ 730.3 million in 2022 and is projected to reach US$ 957.4 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Inactivated Polio Vaccine (IPV) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Poliovirus Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Poliovirus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Poliovirus Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliovirus Vaccine Market Segment Percentages, by Type, 2022 (%)
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Global Poliovirus Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliovirus Vaccine Market Segment Percentages, by Application, 2022 (%)
Public
Private
Global Poliovirus Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliovirus Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Poliovirus Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Poliovirus Vaccine revenues share in global market, 2022 (%)
Key companies Poliovirus Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Poliovirus Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Poliovirus Vaccine, market overview.
Chapter 2: Global Poliovirus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Poliovirus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Poliovirus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Poliovirus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Poliovirus Vaccine Overall Market Size
2.1 Global Poliovirus Vaccine Market Size: 2022 VS 2029
2.2 Global Poliovirus Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Poliovirus Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Poliovirus Vaccine Players in Global Market
3.2 Top Global Poliovirus Vaccine Companies Ranked by Revenue
3.3 Global Poliovirus Vaccine Revenue by Companies
3.4 Global Poliovirus Vaccine Sales by Companies
3.5 Global Poliovirus Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Poliovirus Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Poliovirus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Poliovirus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Poliovirus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Poliovirus Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Poliovirus Vaccine Market Size Markets, 2022 & 2029
4.1.2 Inactivated Polio Vaccine (IPV)
4.1.3 Oral Polio Vaccine (OPV)
4.2 By Type – Global Poliovirus Vaccine Revenue & Forecasts
4.2.1 By Type – Global Poliovirus Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Poliovirus Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Poliovirus Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Poliovirus Vaccine Sales & Forecasts
4.3.1 By Type – Global Poliovirus Vaccine Sales, 2018-2023
4.3.2 By Type – Global Poliovirus Vaccine Sales, 2024-2029
4.3.3 By Type – Global Poliovirus Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Poliovirus Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Poliovirus Vaccine Market Size, 2022 & 2029
5.1.2 Public
5.1.3 Private
5.2 By Application – Global Poliovirus Vaccine Revenue & Forecasts
5.2.1 By Application – Global Poliovirus Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Poliovirus Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Poliovirus Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Poliovirus Vaccine Sales & Forecasts
5.3.1 By Application – Global Poliovirus Vaccine Sales, 2018-2023
5.3.2 By Application – Global Poliovirus Vaccine Sales, 2024-2029
5.3.3 By Application – Global Poliovirus Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Poliovirus Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Poliovirus Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Poliovirus Vaccine Revenue & Forecasts
6.2.1 By Region – Global Poliovirus Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Poliovirus Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Poliovirus Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Poliovirus Vaccine Sales & Forecasts
6.3.1 By Region – Global Poliovirus Vaccine Sales, 2018-2023
6.3.2 By Region – Global Poliovirus Vaccine Sales, 2024-2029
6.3.3 By Region – Global Poliovirus Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Poliovirus Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Poliovirus Vaccine Sales, 2018-2029
6.4.3 US Poliovirus Vaccine Market Size, 2018-2029
6.4.4 Canada Poliovirus Vaccine Market Size, 2018-2029
6.4.5 Mexico Poliovirus Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Poliovirus Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Poliovirus Vaccine Sales, 2018-2029
6.5.3 Germany Poliovirus Vaccine Market Size, 2018-2029
6.5.4 France Poliovirus Vaccine Market Size, 2018-2029
6.5.5 U.K. Poliovirus Vaccine Market Size, 2018-2029
6.5.6 Italy Poliovirus Vaccine Market Size, 2018-2029
6.5.7 Russia Poliovirus Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Poliovirus Vaccine Market Size, 2018-2029
6.5.9 Benelux Poliovirus Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Poliovirus Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Poliovirus Vaccine Sales, 2018-2029
6.6.3 China Poliovirus Vaccine Market Size, 2018-2029
6.6.4 Japan Poliovirus Vaccine Market Size, 2018-2029
6.6.5 South Korea Poliovirus Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Poliovirus Vaccine Market Size, 2018-2029
6.6.7 India Poliovirus Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Poliovirus Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Poliovirus Vaccine Sales, 2018-2029
6.7.3 Brazil Poliovirus Vaccine Market Size, 2018-2029
6.7.4 Argentina Poliovirus Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Poliovirus Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Poliovirus Vaccine Sales, 2018-2029
6.8.3 Turkey Poliovirus Vaccine Market Size, 2018-2029
6.8.4 Israel Poliovirus Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Poliovirus Vaccine Market Size, 2018-2029
6.8.6 UAE Poliovirus Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Poliovirus Vaccine Major Product Offerings
7.1.4 Sanofi Poliovirus Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Poliovirus Vaccine Major Product Offerings
7.2.4 GSK Poliovirus Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Bibcol
7.3.1 Bibcol Company Summary
7.3.2 Bibcol Business Overview
7.3.3 Bibcol Poliovirus Vaccine Major Product Offerings
7.3.4 Bibcol Poliovirus Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Bibcol Key News & Latest Developments
7.4 Serum Institute
7.4.1 Serum Institute Company Summary
7.4.2 Serum Institute Business Overview
7.4.3 Serum Institute Poliovirus Vaccine Major Product Offerings
7.4.4 Serum Institute Poliovirus Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Serum Institute Key News & Latest Developments
7.5 Tiantan Biological
7.5.1 Tiantan Biological Company Summary
7.5.2 Tiantan Biological Business Overview
7.5.3 Tiantan Biological Poliovirus Vaccine Major Product Offerings
7.5.4 Tiantan Biological Poliovirus Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Tiantan Biological Key News & Latest Developments
7.6 IMBCA
7.6.1 IMBCA Company Summary
7.6.2 IMBCA Business Overview
7.6.3 IMBCA Poliovirus Vaccine Major Product Offerings
7.6.4 IMBCA Poliovirus Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 IMBCA Key News & Latest Developments
7.7 Panacea Biotec Ltd
7.7.1 Panacea Biotec Ltd Company Summary
7.7.2 Panacea Biotec Ltd Business Overview
7.7.3 Panacea Biotec Ltd Poliovirus Vaccine Major Product Offerings
7.7.4 Panacea Biotec Ltd Poliovirus Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Panacea Biotec Ltd Key News & Latest Developments
7.8 Bio-Med
7.8.1 Bio-Med Company Summary
7.8.2 Bio-Med Business Overview
7.8.3 Bio-Med Poliovirus Vaccine Major Product Offerings
7.8.4 Bio-Med Poliovirus Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Bio-Med Key News & Latest Developments
7.9 Halfkin Bio-Pharmaceuticals
7.9.1 Halfkin Bio-Pharmaceuticals Company Summary
7.9.2 Halfkin Bio-Pharmaceuticals Business Overview
7.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Major Product Offerings
7.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Halfkin Bio-Pharmaceuticals Key News & Latest Developments
8 Global Poliovirus Vaccine Production Capacity, Analysis
8.1 Global Poliovirus Vaccine Production Capacity, 2018-2029
8.2 Poliovirus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Poliovirus Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Poliovirus Vaccine Supply Chain Analysis
10.1 Poliovirus Vaccine Industry Value Chain
10.2 Poliovirus Vaccine Upstream Market
10.3 Poliovirus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Poliovirus Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Poliovirus Vaccine in Global Market
Table 2. Top Poliovirus Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Poliovirus Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Poliovirus Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Poliovirus Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Poliovirus Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Poliovirus Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Poliovirus Vaccine Product Type
Table 9. List of Global Tier 1 Poliovirus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Poliovirus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Poliovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Poliovirus Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Poliovirus Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Poliovirus Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Poliovirus Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Poliovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Poliovirus Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Poliovirus Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Poliovirus Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Poliovirus Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Poliovirus Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Poliovirus Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Poliovirus Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Poliovirus Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Poliovirus Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Poliovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Poliovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Poliovirus Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Poliovirus Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Poliovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Poliovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Poliovirus Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Poliovirus Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Poliovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Poliovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Poliovirus Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Poliovirus Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Poliovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Poliovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Poliovirus Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Poliovirus Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Poliovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Poliovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Poliovirus Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Poliovirus Vaccine Sales, (K Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Poliovirus Vaccine Product Offerings
Table 48. Sanofi Poliovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Poliovirus Vaccine Product Offerings
Table 52. GSK Poliovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Bibcol Company Summary
Table 55. Bibcol Poliovirus Vaccine Product Offerings
Table 56. Bibcol Poliovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bibcol Key News & Latest Developments
Table 58. Serum Institute Company Summary
Table 59. Serum Institute Poliovirus Vaccine Product Offerings
Table 60. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Serum Institute Key News & Latest Developments
Table 62. Tiantan Biological Company Summary
Table 63. Tiantan Biological Poliovirus Vaccine Product Offerings
Table 64. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Tiantan Biological Key News & Latest Developments
Table 66. IMBCA Company Summary
Table 67. IMBCA Poliovirus Vaccine Product Offerings
Table 68. IMBCA Poliovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. IMBCA Key News & Latest Developments
Table 70. Panacea Biotec Ltd Company Summary
Table 71. Panacea Biotec Ltd Poliovirus Vaccine Product Offerings
Table 72. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Panacea Biotec Ltd Key News & Latest Developments
Table 74. Bio-Med Company Summary
Table 75. Bio-Med Poliovirus Vaccine Product Offerings
Table 76. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Bio-Med Key News & Latest Developments
Table 78. Halfkin Bio-Pharmaceuticals Company Summary
Table 79. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Offerings
Table 80. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Halfkin Bio-Pharmaceuticals Key News & Latest Developments
Table 82. Poliovirus Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Poliovirus Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Poliovirus Vaccine Production by Region, 2018-2023 (K Units)
Table 85. Global Poliovirus Vaccine Production by Region, 2024-2029 (K Units)
Table 86. Poliovirus Vaccine Market Opportunities & Trends in Global Market
Table 87. Poliovirus Vaccine Market Drivers in Global Market
Table 88. Poliovirus Vaccine Market Restraints in Global Market
Table 89. Poliovirus Vaccine Raw Materials
Table 90. Poliovirus Vaccine Raw Materials Suppliers in Global Market
Table 91. Typical Poliovirus Vaccine Downstream
Table 92. Poliovirus Vaccine Downstream Clients in Global Market
Table 93. Poliovirus Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Poliovirus Vaccine Segment by Type in 2022
Figure 2. Poliovirus Vaccine Segment by Application in 2022
Figure 3. Global Poliovirus Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Poliovirus Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Poliovirus Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Poliovirus Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Poliovirus Vaccine Revenue in 2022
Figure 9. By Type - Global Poliovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Poliovirus Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Poliovirus Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Poliovirus Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Poliovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Poliovirus Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Poliovirus Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Poliovirus Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Poliovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Poliovirus Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Poliovirus Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Poliovirus Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Poliovirus Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Poliovirus Vaccine Sales Market Share, 2018-2029
Figure 23. US Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Poliovirus Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Poliovirus Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Poliovirus Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Poliovirus Vaccine Sales Market Share, 2018-2029
Figure 37. China Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Poliovirus Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Poliovirus Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Poliovirus Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Poliovirus Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Poliovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Poliovirus Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Poliovirus Vaccine by Region, 2022 VS 2029
Figure 54. Poliovirus Vaccine Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ポリオウイルスワクチンの世界市場見通し2023年-2029年(Poliovirus Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ポリオウイルスワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp